Who is sponsoring NCT06958588?

NCT06958588 is sponsored by Science Valley Research Institute.

What drugs are being tested in NCT06958588?

Interventions in NCT06958588: Experimental: Hyperslim, Active Comparator #1.

What condition does NCT06958588 study?

NCT06958588 studies Venous Thromboembolism (VTE), Intensive Care Medicine, Venous Thromboembolism.

Is NCT06958588 still recruiting?

NCT06958588 is currently recruiting now. Last updated 6 May 2025.

Last reviewed 2025-05-06 · How we verify

NCT06958588: SOPHIE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pulsed Electromagnetic Field Therapy or Pneumatic Compression VTE Prophylaxis

Recruiting now Phase 4 Last updated 6 May 2025

What this trial tests

Phase 4 trial testing Experimental: Hyperslim in Venous Thromboembolism (VTE) in 50 participants. Currently enrolling.

Timeline

25 May 2025

Primary endpoint
20 December 2025

20 March 2026

Quick facts

Lead sponsor	Science Valley Research Institute
Phase	Phase 4
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	50
Start date	25 May 2025
Primary completion	20 December 2025
Estimated completion	20 March 2026
Sites	1 location across Brazil

Drugs / interventions tested

Experimental: Hyperslim
Active Comparator #1 — full drug profile →

Conditions studied

Venous Thromboembolism (VTE) — all drugs for Venous Thromboembolism (VTE) →
Intensive Care Medicine — all drugs for Intensive Care Medicine →
Venous Thromboembolism — all drugs for Venous Thromboembolism →

Sponsor

Science Valley Research Institute

Who can join

Eligibility, any sex, with Venous Thromboembolism (VTE) or Intensive Care Medicine. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Venous thromboembolism (VTE) is frequent in patients in the intensive care unit (ICU). Pharmacologic prophylaxis is sometimes contraindicated, and mechanical prophylaxis is used. The primary objective of the study is to compare Pulsed Electromagnetic Field Therapy (PEMF) with conventional mechanical prophylaxis for the prevention of VTE in patients in the ICU.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Pulsed Electromagnetic Field Therapy Compared to Conventional Mechanical Prophylaxis for Venous Thromboembolism Prophylaxis in The Intensive Care Unit - Rationale and Design for The SOPHIE Trial.
Sad EF, Neves S, Portugal MF, Santana VDS, et al · · 2025 · PMID 41252332 · DOI 10.1177/10760296251392909

Verify or expand the search:

Other recruiting trials for Venous Thromboembolism (VTE)

Currently open trials in the same condition.

NCT07310693 — External Validation of the CLOVER Score for Detecting Occult Cancer in Venous Thromboembolism Patients · recruiting
NCT07015905 — REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults · Phase 3 · recruiting
NCT06845423 — Prevention of Postpartum Venous Thromboembolism in Women at Intermediate Risk · Phase 4 · recruiting
NCT06731673 — Heat Shock Protein 47 in Thrombosis · recruiting
NCT07439991 — Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery · recruiting

Other Science Valley Research Institute trials

Trials by the same sponsor.

NCT06974526 — Subdermal Implant-bioabsorbable Oxandrolone Pellet For Rehabilitation Following Anterior Cruciate Ligament (ACL) Surgica · Phase 2 · recruiting
NCT06980961 — Short and Ultra-short-pulse ND: YAG 1064nm Lasers (Omer Smart and Omer Premium) for Stasis Dermatitis · NA · recruiting
NCT06873321 — VTE Incidence After Rivaroxaban + Aspirin or SAPT After Lower-limb Revascularization · Phase 4 · recruiting
NCT06136208 — Pharmacokinetic Aspects of 25-mg Estradiol Pellet in Climacteric Women · NA · completed
NCT05570786 — Subdermal Implant-bioabsorbable Gestrinone Pellet for Endometriosis Pelvic Pain Treatment · Phase 2 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06958588 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Science Valley Research Institute
Last refreshed: 6 May 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06958588.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing